Enzon Pharmaceuticals, Inc., along with its various subsidiaries, primarily focuses on the commercialization of pharmaceutical products. PegIntron is a key drug within its actively marketed portfolio. The company also maintains a specific marketing agreement for the medication Vicineum. Established in 1981, Enzon Pharmaceuticals is headquartered in Cranford, New Jersey.